Sökning: "Placebo"
Visar resultat 26 - 30 av 442 avhandlingar innehållade ordet Placebo.
26. Premenstrual dysphoric disorder in relation to neuroactive steroids and alcohol
Sammanfattning : Introduction: Premenstrual Dysphoric Disorder (PMDD) is a condition that affects about 2-6% of women of reproductive age. The relation to ovarian steroids is apparent as symptoms are absent during anovulatory cycles. LÄS MER
27. Effects of perioperative nutrition on insulin action in postoperative metabolism
Sammanfattning : Surgical operations are a fundamental part of contemporary treatment of disease. For example, 43 % of in-patients in Sweden undergo a surgical operation. Surgery is not yet without significant risks. Infectious complication rates following abdominal surgery, for instance, remain at 9-25 %. LÄS MER
28. The Role of Zinc in Leishmaniasis and Tuberculosis
Sammanfattning : The synergistic relation between nutritional deficiency and infection may have negative effects on the immune system, making individuals more vulnerable to infection. Zinc can affect the resistance to infections by modulating cytokine release, and by acting as a cofactor of thymulin, which induces the differentiation of immature T lymphocytes. LÄS MER
29. Thromboembolism following orthopaedic surgery : outcome and diagnostic procedures after prophylaxis in lower limb injuries
Sammanfattning : Deep vein thrombosis (DVT) and pulmonary embolism (PE) frequently occur after major orthopaedic surgery. The clinical assessment of DVT and PE is unreliable and most cases are asymptomatic. However, even in asymptomatic DVTs, the risk for a PE is considerable. LÄS MER
30. Clinical impact of epoetins in the treatment of anemia with special emphasis on patients with lymphoid malignancies. : dosing, iron supplementation and safety
Sammanfattning : The aim of this thesis was to determine the relevant dose of arbepoetin-alfa (DA) in patients with lymphoproliferative diseases (LPD) and chemotherapy induced anemia (CIA), to study the clinical impact of intravenous (IV) iron supplementation combined with epoetin beta treatment, to identify factors that might predict hemoglobin (Hb) response to treatment with epoetins and to investigate safety of DA.A dose-finding phase II study was able to assess a reasonable DA dose of 2. LÄS MER